D-dimer Test

The measured fragments arise after thrombin converts fibrinogen into fibrin and factor XIII stabilizes the fibrin network. Plasmin subsequently degrades that cross-linked structure, releasing D-dimer fragments that an immunoassay can detect. This sequence links the laboratory signal to clot formation followed by breakdown, rather than to circulating fibrinogen alone.

Elevated D-dimer levels can accompany inflammation, infection, pregnancy, trauma, cancer, or older age, in addition to clot breakdown associated with venous thromboembolism. These conditions make the result nonspecific: a positive value may reflect several clinical processes. Consequently, clinicians generally need further evaluation rather than treating the result as proof of a clot.

A normal result can help rule out venous thromboembolism when the patient has a low or intermediate pretest probability, meaning the initial clinical likelihood is not high. In that setting, the negative finding is clinically useful for suspected deep vein thrombosis or pulmonary embolism. Its value therefore depends on the patient’s initial clinical assessment.

An elevated result shows that detectable D-dimer fragments are present, but it does not identify a single cause. Because D-dimer is sensitive but nonspecific, the finding can occur with venous thromboembolism or several other conditions. A positive test therefore generally prompts further evaluation, rather than serving as a stand-alone diagnosis of deep vein thrombosis or pulmonary embolism.

Pretest probability determines how much confidence clinicians can place in a normal result. For patients with low or intermediate clinical probability of venous thromboembolism, a normal level can help rule out suspected disease. The overview does not support using the test result in isolation, since elevated values require context and generally lead to additional evaluation.

The D-dimer test contributes to evaluation of suspected venous thromboembolism, particularly deep vein thrombosis and pulmonary embolism. Its main clinical contribution is helping reduce the likelihood of these conditions when the result is normal and pretest probability is low or intermediate. An elevated result remains nonspecific, so clinicians generally investigate further rather than assigning a diagnosis from it alone.